Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK500924PMID: 29999983
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 343306-71-8
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the clinical use of sugammadex during breastfeeding. Because sugammadex is a large, highly polar molecule with a molecular weight of 2002 Da., the amount in milk is likely to be very low and oral absorption by the infant is unlikely. Sugammadex is acceptable to use during breastfeeding.[1,2]
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
References
- 1.
- Schaller SJ, Fink H. Sugammadex as a reversal agent for neuromuscular block: An evidence-based review. Core Evid. 2013;8:57–67. [PMC free article: PMC3789633] [PubMed: 24098155]
- 2.
- Richardson MG, Raymond BL. Sugammadex administration in pregnant women and in women of reproductive potential: A narrative review. Anesth Analg. 2020;130:1628–37. [PubMed: 31283616]
Substance Identification
Substance Name
Sugammadex
CAS Registry Number
343306-71-8
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- LactMed App
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PMCPubMed Central citations
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Lanadelumab.[Drugs and Lactation Database (...]Review Lanadelumab.. Drugs and Lactation Database (LactMed®). 2006
- Review Caplacizumab.[Drugs and Lactation Database (...]Review Caplacizumab.. Drugs and Lactation Database (LactMed®). 2006
- Review Ecallantide.[Drugs and Lactation Database (...]Review Ecallantide.. Drugs and Lactation Database (LactMed®). 2006
- Review Ocrelizumab.[Drugs and Lactation Database (...]Review Ocrelizumab.. Drugs and Lactation Database (LactMed®). 2006
- Review Guselkumab.[Drugs and Lactation Database (...]Review Guselkumab.. Drugs and Lactation Database (LactMed®). 2006
- Sugammadex - Drugs and Lactation Database (LactMed®)Sugammadex - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...